These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21591386)

  • 1. [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].
    Gafurova RM; Abdullaev AA; Kadieva IA; Islamova UA; Mutalipov KhM
    Kardiologiia; 2010; 50(12):15-8. PubMed ID: 21591386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
    Tereshchenko SN; Aleksandriia LG; Moiseev VS
    Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].
    Dabrowski R; Pedzich-Placha E
    Kardiol Pol; 2010 Jul; 68(7):810-3; discussion 814. PubMed ID: 20648444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.
    Law Y
    J Am Coll Cardiol; 2005 Jul; 46(1):181-2; author reply 183. PubMed ID: 15992657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation of converting enzyme inhibitors in patients, survivors of myocardial infarction].
    Vertkin AL; Skotnikov AS
    Kardiologiia; 2008; 48(7):14-7. PubMed ID: 18789020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
    MMW Fortschr Med; 2002 Nov; 144(45):58. PubMed ID: 12534067
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
    Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
    Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.
    Konishi M; Haraguchi G; Yoshikawa S; Kimura S; Inagaki H; Isobe M
    Circ J; 2011; 75(8):1982-91. PubMed ID: 21697605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.
    Seino Y
    Circ J; 2011; 75(8):1829-30. PubMed ID: 21737949
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction].
    Bakaev RG; Strutynskiĭ AV; Kallaeva AN; Glazunov AB; Voronina MA; Pekhtereva DA; Moshkova NK; Chudnovskaia EA; Kochetkov BM
    Klin Med (Mosk); 2011; 89(1):23-6. PubMed ID: 21516760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of medical use of Korvazan® for restorative treatment of patients with myocardial infarction, counting the risk factors].
    Vakaliuk IP; Tymochko NB
    Lik Sprava; 2013 Dec; (8):94-9. PubMed ID: 25726684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
    Agaev MM; Azizov VA
    Kardiologiia; 2003; 43(2):29-34. PubMed ID: 12891269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
    Willenheimer R; van Veldhuisen DJ; Ponikowski P; Lechat P;
    J Am Coll Cardiol; 2005 Jul; 46(1):182. PubMed ID: 15992659
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension].
    Iarkova NA; Borovkov NN
    Klin Med (Mosk); 2009; 87(10):25-9. PubMed ID: 20017346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
    Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
    J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early administration of ramipril in acute myocardial infarction: neurohormonal and hemodynamic effects and tolerability.
    van der Ent M; Remme WJ; Bartels GL; Kruijssen DA; Krauss XH; van Hoogenhuyze DC
    Cardiology; 1997; 88(6):548-55. PubMed ID: 9397311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.